Blue Owl Capital Holdings’s Pliant Therapeutics PLRX Stock Holding History

Blue Owl Capital Holdings’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,969,199	Closed	-$3.74M	–	90
2026 Q1	$3.74M	Hold	2,969,199	–	–	1.01%	26
2025 Q4	$3.62M	Hold	2,969,199	–	–	1.12%	26
2025 Q3	$4.39M	Hold	2,969,199	–	–	1.36%	23
2025 Q2	$3.44M	Hold	2,969,199	–	–	1.11%	24
2025 Q1	$4.01M	Buy	2,969,199 +200,000	+7%	+$1.21M	1.29%	21
2024 Q4	$36.5M	Sell	2,769,199 -235,000	-8%	-$3.21M	8.4%	3
2024 Q3	$33.7M	Hold	3,004,199	–	–	6.5%	4
2024 Q2	$32.3M	Hold	3,004,199	–	–	8.98%	2
2024 Q1	$44.8M	Hold	3,004,199	–	–	8.94%	3
2023 Q4	$54.4M	Buy	+3,004,199	New	+$45.7M	13.01%	1

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Blue Owl Capital Holdings's PLRX Position: Q2 2026 in Review

Blue Owl Capital Holdings sold out of Pliant Therapeutics (PLRX) in Q2 2026, closing a stake of 2,969,199 shares — an estimated $3.74M sold.

Blue Owl Capital Holdings first reported a position in PLRX in Q4 2023 and held it in 10 quarters. The position peaked at $54.4M in Q4 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

Blue Owl Capital Holdings reported no remaining Pliant Therapeutics position as of Q2 2026 after selling out during the quarter.
Blue Owl Capital Holdings sold 2,969,199 Pliant Therapeutics shares in Q2 2026, an estimated $3.74M.
Blue Owl Capital Holdings first reported a position in Pliant Therapeutics in Q4 2023 and held it in 10 quarters.
Blue Owl Capital Holdings's Pliant Therapeutics position peaked at $54.4M in Q4 2023.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Blue Owl Capital Holdings's 13F filing for Q2 2026, filed 11 Aug 2026.